IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,370,965 | -5.2% | 301,311 | +46.7% | 0.00% | 0.0% |
| Q2 2023 | $1,445,720 | -38.5% | 205,358 | -46.7% | 0.00% | -33.3% |
| Q1 2023 | $2,352,454 | -10.3% | 385,017 | -6.2% | 0.00% | -25.0% |
| Q4 2022 | $2,622,028 | -99.9% | 410,333 | +0.1% | 0.00% | -33.3% |
| Q3 2022 | $3,928,633,000 | +214.8% | 410,087 | +262.8% | 0.01% | +200.0% |
| Q2 2022 | $1,247,895,000 | -61.2% | 113,034 | -41.5% | 0.00% | -50.0% |
| Q1 2022 | $3,218,695,000 | +316.8% | 193,315 | +377.8% | 0.00% | +300.0% |
| Q4 2021 | $772,305,000 | -56.1% | 40,456 | -43.3% | 0.00% | -50.0% |
| Q3 2021 | $1,760,108,000 | +2870.7% | 71,375 | +3034.6% | 0.00% | – |
| Q2 2021 | $59,248,000 | -73.1% | 2,277 | -67.3% | 0.00% | – |
| Q1 2021 | $220,544,000 | -3.8% | 6,966 | +41.0% | 0.00% | – |
| Q4 2020 | $229,262,000 | +89.6% | 4,941 | +34.5% | 0.00% | – |
| Q3 2020 | $120,915,000 | -87.6% | 3,673 | -89.6% | 0.00% | -100.0% |
| Q2 2020 | $973,597,000 | -42.9% | 35,468 | -37.8% | 0.00% | -50.0% |
| Q1 2020 | $1,706,415,000 | +277.1% | 57,004 | +248.7% | 0.00% | +300.0% |
| Q4 2019 | $452,540,000 | +19.8% | 16,349 | -21.2% | 0.00% | 0.0% |
| Q3 2019 | $377,632,000 | +17.9% | 20,749 | +58.8% | 0.00% | 0.0% |
| Q2 2019 | $320,354,000 | +53.1% | 13,065 | -40.6% | 0.00% | – |
| Q1 2019 | $209,220,000 | +591.4% | 22,000 | +717.8% | 0.00% | – |
| Q3 2018 | $30,262,000 | -12.1% | 2,690 | 0.0% | 0.00% | – |
| Q2 2018 | $34,432,000 | -86.3% | 2,690 | -81.9% | 0.00% | – |
| Q1 2018 | $250,813,000 | +150.7% | 14,841 | +18.7% | 0.00% | – |
| Q4 2017 | $100,032,000 | +110.3% | 12,504 | +103.7% | 0.00% | – |
| Q3 2017 | $47,570,000 | +0.5% | 6,138 | -4.7% | 0.00% | – |
| Q2 2017 | $47,349,000 | – | 6,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |